chr19-9856753-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_058164.4(OLFM2):c.687+54G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0559 in 1,461,562 control chromosomes in the GnomAD database, including 2,699 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.039 ( 165 hom., cov: 32)
Exomes 𝑓: 0.058 ( 2534 hom. )
Consequence
OLFM2
NM_058164.4 intron
NM_058164.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.0610
Genes affected
OLFM2 (HGNC:17189): (olfactomedin 2) Involved in positive regulation of smooth muscle cell differentiation. Acts upstream of or within protein secretion. Located in cytoplasm; extracellular region; and nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 19-9856753-C-T is Benign according to our data. Variant chr19-9856753-C-T is described in ClinVar as [Benign]. Clinvar id is 1286451.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.057 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OLFM2 | NM_058164.4 | c.687+54G>A | intron_variant | ENST00000264833.9 | |||
OLFM2 | NM_001304347.2 | c.759+54G>A | intron_variant | ||||
OLFM2 | NM_001304348.2 | c.453+54G>A | intron_variant | ||||
OLFM2 | XM_047439713.1 | c.483+54G>A | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OLFM2 | ENST00000264833.9 | c.687+54G>A | intron_variant | 1 | NM_058164.4 | ||||
OLFM2 | ENST00000590841.5 | c.453+54G>A | intron_variant | 2 | |||||
OLFM2 | ENST00000593091.2 | c.759+54G>A | intron_variant | 5 | P1 | ||||
OLFM2 | ENST00000592448.1 | c.*92+54G>A | intron_variant, NMD_transcript_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.0394 AC: 5999AN: 152134Hom.: 165 Cov.: 32
GnomAD3 genomes
AF:
AC:
5999
AN:
152134
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0578 AC: 75682AN: 1309310Hom.: 2534 AF XY: 0.0571 AC XY: 37256AN XY: 652528
GnomAD4 exome
AF:
AC:
75682
AN:
1309310
Hom.:
AF XY:
AC XY:
37256
AN XY:
652528
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0394 AC: 5996AN: 152252Hom.: 165 Cov.: 32 AF XY: 0.0390 AC XY: 2907AN XY: 74444
GnomAD4 genome
AF:
AC:
5996
AN:
152252
Hom.:
Cov.:
32
AF XY:
AC XY:
2907
AN XY:
74444
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
46
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 20, 2021 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at